- Chronic Heart Failure
- Renal Failure and Cardiovascular Disease
- Diabetes and the Heart
- Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors
- Stable Coronary Artery Disease (CAD)
Improving mortality, heart failure and renal outcomes for our patients. Is the evidence for SGLT2i enough for a paradigm shift for practicing cardiologists?
The Asian Pacific Society of Cardiology (APSC) represents 22 cardiology societies in the Asia-Pacific region.
Scientific and Education Activities include APSC Scholarship, Emerging Leadership...
The Asian Pacific Society of Cardiology (APSC) represents 22 cardiology societies in the Asia-Pacific region.
Scientific and Education Activities include APSC Scholarship, Emerging Leadership Course Programs, Joint Symposia and Series of Webinars/online sessions held with other major international societies and with APSC Member Societies at their annual meetings.